Grants to Conquer the ‘Digital Divide’

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 11
Volume 9
Issue 11

BETHESDA, Md-The National Cancer Institute has given four awards totaling $932,000 to four existing NCI contractors to develop research to understand, and pilot programs to breach, the “Digital Divide” that prevents many members of minorities from accessing cancer information on the Internet.

BETHESDA, Md—The National Cancer Institute has given four awards totaling $932,000 to four existing NCI contractors to develop research to understand, and pilot programs to breach, the “Digital Divide” that prevents many members of minorities from accessing cancer information on the Internet.

The four awards went to contractors who operate regional information centers for NCI’s Cancer Information Service (CIS). They will cover 1 year, with the possibility of a 6-month extension.

The awardees are the CIS New York State (Memorial Sloan-Kettering Cancer Center); CIS North Central and Mid-West Regions (University of Wisconsin, Madison, and Karmanos Cancer Center, Detroit); CIS New England Region (Yale Cancer Center); and CIS Mid-South Region (Markey Cancer Cener, Kentucky, and the Louisiana State University Health Sciences Center).

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content